Innoviva, Inc. (INVA)
INVANASDAQ-GSBiotechnology: Pharmaceutical Preparations
$19.22
+0.2200 (+1.16%) today
Regular session, Nov 10, 2:04 PM ET
- Market cap
- $1.37bn
- P/E
- 5.5
- EPS, last 4 quarters
- $3.47
- Dividend yield
- –
- Day range
- $18.80 to $20.10
- 52-week range
- $18.70 to $25.15
- Average volume
- 891.1k
- Previous close
- $19.00
Analysts
3 coveringBuy3 buy, 0 hold, 0 sell
Targets a year out average $34.00, +76.9% from here
Earnings
next estimate $0.4800Next report
Dec 2025
+470.6%
Mar 2026
+2.3%
Jun 2026
+5.4%
Sep 2026
+2.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $114.61m | $97.99m | $119.59m | $106.12m |
| Gross profit | $75.67m | $75.83m | $90.62m | $84.38m |
| Operating income | $38.99m | $38.15m | $50.85m | $42.15m |
| Net income | $164.15m | $186.59m | -$83.42m | -$73.89m |
Last four quarters: revenue $438.32m, margin 44.1%, free cash flow $182.51m
News
8 latest- Is Innoviva (INVA) Stock Undervalued Right Now?Zacks · 5 hours ago
- INVA or MRK: Which Is the Better Value Stock Right Now?Zacks · 1 day ago
- Innoviva (INVA) Tops Q3 Earnings EstimatesZacks · 6 days ago
- Pfizer (PFE) Surpasses Q3 Earnings and Revenue EstimatesZacks · Nov 3, 2026
- AbbVie (ABBV) Tops Q3 Earnings and Revenue EstimatesZacks · Oct 30, 2026
- Eli Lilly (LLY) Surpasses Q3 Earnings and Revenue EstimatesZacks · Oct 29, 2026
- Do Options Traders Know Something About Innoviva Stock We Don't?Zacks · Oct 12, 2026
- INVA vs. MRK: Which Stock Is the Better Value Option?Zacks · Oct 8, 2026
The company
Innoviva is a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ('IST'), and a portfolio of strategic investments in healthcare assets. Innoviva's royalty portfolio includes respiratory assets partnered with Glaxo Group Limited ('GSK').
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- inva.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.